Key result
Analysis of over 30,000 tumor and normal samples using CTAT-VIF identified over 30,000 virus-human DNA or RNA junctions at more than 20,000 insertion loci, revealing viral cancer-insertion hotspots.
Why the study?
Detecting viral DNA insertions from next-generation sequencing data defines viral associations with diseases and provides mechanistic insights, motivating the development of a tool to survey insertions using DNA and RNA sequencing data.
Observational (n=33,762)
The development and application of VirusIntegrationFinder across >30,000 samples provides a comprehensive catalog of viral genome integrations and their functional impacts in human cancers.
Catalog advances viral integration research in cancer; leaves open any clinical applications.
Viruses are a leading cause of human morbidity and mortality. Certain viruses, including human papillomaviruses (HPVs), play a significant role in the etiology of cancer. Detection of viral DNA insertions in the human genome from next generation sequencing data defines viral associations with cancer and other diseases, identifies impacted organs and tissues, provides insights into disease mechanisms and has the potential to enhance clinical evaluations. In this study, we developed VirusIntegrationFinder (CTAT-VIF), a tool for surveying human genome insertions of various human viruses using both DNA and RNA sequencing data. We applied CTAT-VIF to analyze a dataset of over 30,000 tumor and normal samples, as well as more than 1,000 cancer cell lines. This effort resulted in the compilation of a catalog of over 30,0000 virus-human DNA or RNA junctions at more than 20,000 insertion loci and reassessed viral cancer-insertion hotspots across the human genome. Furthermore, we characterized the functional impacts of insertions with respect to human copy number alterations, effects on the expression of flanking human genes, and the identification of potentially oncogenic chimeric human and human/virus fusion transcripts at insertion loci. In addition to confirming known viral associations with specific tumor types, our study revealed both shared and virus-specific insertion hotspots in addition to variable functional impacts based on virus type. Besides some rare events of interest, we also found evidence for sequencing contamination, which underscores the need for vigilance when studying viral content or genome integrations.
No takes yet. Share an insight, caveat, or question.
Haas et al. (2025) conducted an observational in Cancer and viral infections (n=33,762). Viral genome integrations vs. Unexposed/reference genomic regions was evaluated on Virus-human DNA or RNA junctions and insertion loci. Analysis of over 30,000 tumor and normal samples using CTAT-VIF identified over 30,000 virus-human DNA or RNA junctions at more than 20,000 insertion loci, revealing viral cancer-insertion hotspots.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: